Rapid Biofabrication of an Advanced Microphysiological System Mimicking Phenotypical Heterogeneity and Drug Resistance in Glioblastoma
Advanced Healthcare Materials · 2024-12 · 13 (30)
DOI: 10.1002/adhm.202401876 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 05.08.2024. Verfasst von Sirjana Pun und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, University of Cincinnati, Cincinnati, OH, 45221, USA. Hauptthemen laut MEDLINE: Glioblastoma, Drug Resistance, Neoplasm, Temozolomide, Bioprinting. Die Arbeit wurde bisher 41-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: University of Cincinnati, the Brain Tumor Center Research Award, University of Cincinnati, Neurobiology Research Center Research Award.
Abstract (Originalsprache)
Microphysiological systems (MPSs) reconstitute tissue interfaces and organ functions, presenting a promising alternative to animal models in drug development. However, traditional materials like polydimethylsiloxane (PDMS) often interfere by absorbing hydrophobic molecules, affecting drug testing accuracy. Additive manufacturing, including 3D bioprinting, offers viable solutions. GlioFlow3D, a novel microfluidic platform combining extrusion bioprinting and stereolithography (SLA) is introduced. GlioFlow3D integrates primary human cells and glioblastoma (GBM) lines in hydrogel‐based microchannels mimicking vasculature, within an SLA resin framework using cost‐effective materials. The study introduces a robust protocol to mitigate SLA resin cytotoxicity. Compared to PDMS, GlioFlow3D demonstrated lower small molecule absorption, which is relevant for accurate testing of small molecules like Temozolomide (TMZ). Computational modeling is used to optimize a pumpless setup simulating interstitial fluid flow dynamics in tissues. Co‐culturing GBM with brain endothelial cells in GlioFlow3D showed enhanced CD133 expression and TMZ resistance near vascular interfaces, highlighting spatial drug resistance mechanisms. This PDMS‐free platform promises advanced drug testing, improving preclinical research and personalized therapy by elucidating complex GBM drug resistance mechanisms influenced by the tissue microenvironment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Engineering, University of Cincinnati, Cincinnati, OH, 45221, USA.
- Abbvie, Worcester, Massachusetts, 01605, USA.
- Thermo Fisher Scientific, Waltham, Massachusetts, 02451, USA.
- Department of Neurology, University of Cincinnati, Cincinnati, OH, 45219, USA.
- Department of Neurosurgery, University of North Carolina, Chapel Hill, NC, 27599, USA.
- Institute of Mechanics and Engineering-12 M, University of Bordeaux, Bordeaux, 33607, France.
ORCID-Profile: Sirjana Pun, Daniel Pomeranz Krummel, Riccardo Barrile
Förderung
- University of Cincinnati, the Brain Tumor Center Research Award
- University of Cincinnati, Neurobiology Research Center Research Award
Zitieren
APA
Pun, S., Prakash, A., Demaree, D., Krummel, D. P., Sciumè, G., Sengupta, S., & Barrile, R. (2024). Rapid Biofabrication of an Advanced Microphysiological System Mimicking Phenotypical Heterogeneity and Drug Resistance in Glioblastoma. Advanced Healthcare Materials, 13(30). https://doi.org/10.1002/adhm.202401876
Vancouver
Pun S, Prakash A, Demaree D, Krummel DP, Sciumè G, Sengupta S, et al. Rapid Biofabrication of an Advanced Microphysiological System Mimicking Phenotypical Heterogeneity and Drug Resistance in Glioblastoma. Advanced Healthcare Materials. 2024;13(30). doi:10.1002/adhm.202401876
BibTeX
@article{Pun2024,
author = {Pun, Sirjana and Prakash, Anusha and Demaree, Dalee and Krummel, Daniel Pomeranz and Sciumè, Giuseppe and Sengupta, Soma and Barrile, Riccardo},
title = {Rapid Biofabrication of an Advanced Microphysiological System Mimicking Phenotypical Heterogeneity and Drug Resistance in Glioblastoma},
journal = {Advanced Healthcare Materials},
year = {2024},
volume = {13},
number = {30},
doi = {10.1002/adhm.202401876}
}
EUVIMED